Sascha Berger

a passionate life science VC - dreamer and doer at NEOM - traveler - dad - fcbayern supporter - this is my personal account/opinion

[Sascha Berger @MrBergerVC]

@SaudiAirlines Quite frustrating: Alfursan Gold member, 100k+ miles, but redemption was never enabled on my account.

Support unable to help. This effectively blocks use of miles.

Please escalate and resolve.

[RGMBS @rgmbs]

The inaugural #Saudi Biotechnology Investment Forum #SBIF ⁦@NEOM⁩

#RGMBS2024

[RGMBS @rgmbs]

In the inaugural #Saudi Biotechnology Investment Forum #SBIF, esteemed judges khalid Alburikan - Cornelia Jahnel Sascha Berger - Tarek Ahmed

Interacted with promising innovators across medical biotechnology, small molecules, space research, composte-to-platic recycling!
#RGMBS2024

[Sascha Berger @MrBergerVC]

Had great fun with my colleagues from @NEOM @Tarekistweeting at the inaugural Saudi Biotech Investment Forum #SBIF #RGMBS24 @rgmbs

[Sascha Berger @MrBergerVC]

@rgmbs Happy to be a jury member. This was a good showcase of the emerging Saudi biotech scene

[Sascha Berger @MrBergerVC]

The COVID-19 crisis challenges the way VC Investors work and interact with entrepreneurs.
I truly believe financing innovation in a post-COVID-19 world will (have to) be different. What do you think?

https://t.co/NWD11pXb2C

#venturecapital #covid19 #lifesciences

[CENTOGENE @Centogene]

#CENTOGENE (CNTG) is now listed on the @Nasdaq, reaching yet another milestone for the company. Employees celebrated in our offices around the world to watch the live bell ringing ceremony in New York. Read more about the CENTOGENE story so far: https://t.co/JKdIOmVeA1

[Sascha Berger @MrBergerVC]

@tvmcapital is very active again on the #DBT2019 Deutsche Biotechnologietage 2019 in Würzburg with my colleagues Daniel Parera on a Panel yesterday, Stefan Fischer and myself on Monday. #LifeScience #VentureCapital

[Sascha Berger @MrBergerVC]

Great round of panelist discussing „Digital/AI transforming pharma and healthcare“ at the TVM Capital Winter Conference 2019 in Kitzbühel. Thanks to Gunnar Trommer, Bart De Witte, Bruno Villetelle and Dominik L. Michels (and my co-host Daniel Parera)

[Sascha Berger @MrBergerVC]

Great Strategy! Will do the same ✌️

[Robert Nelsen @rtnarch]

Because of market weakness, ARCH will now be focusing on high-impact private-pay consumer pharmaceuticals related to Bigfoot, like this one. The key diligence insight is “how do you know it doesn’t work?” Take that, FDA. https://t.co/1S3SSC59Ob

[TVM Capital Life Science @tvmcapital]

Molecular diagnostics and pharmaceutical product development - how to work together to maximize value for all stakeholders - a panel discussion at our Autumn Conference #lifescience #venturecapital #innovation

[TVM Capital Life Science @tvmcapital]

Great discussionon alternative strategies to reach public markets - debunking the bias towards RTOs at our Montreal Autumn conference #VentureCapital

[TVM Capital Life Science @tvmcapital]

Happy to announce a Eur 25 m financing @Centogene! #lifescience #RareDiseases #GeneticTesting https://t.co/acjXDoyFGi

[TVM Capital Life Science @tvmcapital]

Meet the TVM Capital Life Science Billion Dollar Club- discussing how they got there...#WiCo 2017

[TVM Capital Life Science @tvmcapital]

Neurimmune and TVM Capital Life Science Create AL-S Pharma to Develop Innovative Therapy for Patients with ALS https://t.co/XReVbd0n6V #ALS

[TVM Capital Life Science @tvmcapital]

Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis https://t.co/t618IIqrBE #lifesciences

[TVM Capital Life Science @tvmcapital]

Funding the Funders panel starting now! #BIOEUROPE @EBDgroup @LillyPad

[TVM Capital Life Science @tvmcapital]

Luc Marengere welcomes <170 attendees at our Montreal Autumn Confernce today. #TVMLifeScience #TVmAutumnConference https://t.co/ceHJoqArHi

[Novateur Ventures @NovateurBio]

Thank you @TVMCapital for great event #TVMLifeScience #TMVAutumnConference today

[Vala Afshar @ValaAfshar]

Tech Valley

1 Apple
2 Google
3 Salesforce
4 Facebook
5 Oracle
6 Cisco
7 Intel
8 Uber
9 Airbnb
10 Dropbox
11 Twitter